|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | ||
| Noncash operating lease expense | ||
| Amortization of deferred commissions | ||
| Equity-based compensation | ||
| Other noncash operating activities, net | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | ||
| Deferred commissions | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Deferred revenue | ||
| Accrued and other liabilities | ||
| Net cash provided by operating activities | ||
| Investing activities: | ||
| Purchases of property and equipment | ||
| Acquisition of business, net of cash acquired | ||
| Other investing activities | ||
| Net cash (used in) provided by investing activities | ||
| Financing activities: | ||
| Payments of deferred offering costs | ||
| Proceeds from option exercises | ||
| Proceeds from Employee Stock Purchase Plan | ||
| Payments for taxes related to net share settlement of equity awards | ||
| Repurchase of LLC Units | ||
| Proceeds from initial public offering, net of underwriting discounts and commissions | ||
| Proceeds from Secondary Offering | ||
| Net cash provided by (used in) financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net increase in cash and cash equivalents | ||
| Cash and cash equivalents - Beginning of period | ||
| Cash and cash equivalents - End of period | ||
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Supplemental disclosures of noncash investing and financing activities | ||
| Purchases of property and equipment included in liabilities | ||
| Lease liabilities arising from obtaining right-of-use assets | ||
| Deferred offering costs, accrued but unpaid |
Loading...
